Trial intelligence / Profile preview

Low-dose fentanyl supplementation with reduced-dose propofol during electroconvulsive therapy

TCTR20201127005Phase 3Completed

Sponsor
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Start
Sep 2015
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fentanyl, propofol in mental disorder, sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Sep 2015; status: completed.

02

Drugs

fentanylpropofol
03

Conditions

mental disorder

Beyond the preview

Go deeper on TCTR20201127005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20201127005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call